HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Inhibition of monocytes adhesion to the intima of arterial wall by local expression of antisense monocyte chemotactic protein-1].

AbstractOBJECTIVE:
To study the mechanism of monocyte recruitment in atherogenesis and to clarify the effect of monocyte chemotactic protein-1 (MCP-1) in this process.
METHODS:
Femoral arteries isolated from the rabbits which had been fed with a high cholesterol diet and locally perfused with MM-LDL within the artery beforehand, were used as the models. Antisense MCP-1cDNA was transferred into the arterial wall by injecting recombinant LNCX-anti-MCP-1/liposomal complex in the femoral sheath and the periarterial tissue.
RESULTS:
Expression of antisense MCP-1 mediated by recombinant LNCX plasmid/lipsomal complex gene transfer enabled to inhibit MCP-1 gene expression and adhesion of monocyte to the intima.
CONCLUSION:
MCP-1 plays an important role on the recruitment of monocytes in the arterial wall, which provides a potential clue in developing a gene therapy project for the prevention and treatment of atherogenesis.
AuthorsQ Wu, H Qiao, Z Wang, H Zhang, P Liu, M Xu, G Ren, S Zhao, M She
JournalZhonghua bing li xue za zhi = Chinese journal of pathology (Zhonghua Bing Li Xue Za Zhi) Vol. 29 Issue 2 Pg. 107-10 (Apr 2000) ISSN: 0529-5807 [Print] China
PMID11866901 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemokine CCL2
  • DNA, Antisense
  • Lipoproteins, LDL
  • RNA, Messenger
  • oxidized low density lipoprotein
Topics
  • Animals
  • Arteriosclerosis (etiology, pathology)
  • Cell Adhesion
  • Chemokine CCL2 (biosynthesis, genetics)
  • DNA, Antisense (biosynthesis, genetics)
  • Femoral Artery (ultrastructure)
  • Lipoproteins, LDL (pharmacology)
  • Male
  • Monocytes (physiology)
  • Muscle, Smooth, Vascular (metabolism)
  • Myocytes, Smooth Muscle (metabolism)
  • RNA, Messenger (genetics)
  • Rabbits
  • Tunica Intima (ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: